Press Releases

Stocks To Track: The TJX Companies, Inc. (TJX), Laboratory Corporation of America Holdings (LH), Devon Energy Corporation (DVN)


The TJX Companies, Inc. (TJX) fell -0.19% during last trading as the stock lost $-0.14 to finish the day at $75.33 with about 3.72M shares changing hands, compared to its three month average trading volume of 3.54M. The $49.23B market cap company, which fluctuated between $74.94 and $75.64 during the day, currently situated 14.23% above its 52 week low of $67.41 and -9.61% away from its one year high of $83.64. The RSI of 48.24 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

The TJX Companies, Inc. operates as an off-price apparel and home fashions retailer in the United States and internationally. It operates through four segments: Marmaxx, HomeGoods, TJX Canada, and TJX International. The company sells family apparel, including footwear and accessories; home fashions, such as home basics, accent furniture, lamps, rugs, wall décor, decorative accessories, and giftware; seasonal items; jewelry; and other merchandise. It operates stores under the T.J. Maxx, Marshalls, HomeGoods, Winners, HomeSense, T.K. Maxx, and Sierra Trading Post names, as well as operates e-commerce sites,, and As of July 30, 2016, the company operated a total of 3,675 stores in nine countries, which included the United States, Canada, the United Kingdom, Ireland, Germany, Poland, Austria, the Netherlands, and Australia, as well as through three e-commerce sites. The TJX Companies, Inc. was founded in 1956 and is headquartered in Framingham, Massachusetts.

Laboratory Corporation of America Holdings (LH) dropped $-7.83 to close the day at a new closing price of $129.86, a -5.69% decrease in value from its previous closing price that moved the stock 32.79% above its 52 week low of $99.63. A total of 3.67M shares exchanged hands during the day compared with its three month average trading volume of 708.44K. The stock, which fluctuated between $128 and $135.66 during the day, currently situated -8.11% below its 52 week high. The stock is up by 0.58% in the past one month and up by 6.77% over the past three months. With a one year target estimate of $148.06 and RSI of 43.44, the stock still has upside potential, making it a hold for now.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. It also provides specialty testing services in the areas of allergy, diagnostic genetics, women’s health, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and pain management; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, the company provides drug development solutions to the pharmaceutical and biotechnology industries, as well as laboratory testing services. Further, it provides its testing services through a sales force to the physicians, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. The company has collaboration with university, hospital and academic institutions, such as Duke University, The Johns Hopkins University, Boston University, Columbia University, Mt. Sinai Hospital, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlington, North Carolina.

Devon Energy Corporation (DVN) had a light trading with around 3.61M shares changing hands compared to its three month average trading volume of 4.63M. The stock traded between $45.19 and $46.88 before closing at the price of $45.27 with -3.25% change on the day. The Oklahoma City Oklahoma 73102 based company is currently trading 154.33% above its 52 week low of $18.07 and -10.58% below its 52 week high of $50.69. Both the RSI indicator and target price of 43.01 and $53.09 respectively, lead us to believe that it should be put on hold over the coming weeks.

Devon Energy Corporation, an independent energy company, primarily engages in the exploration, development, and production of oil, natural gas, and natural gas liquids (NGLs) in the United States and Canada. It operates approximately 19,000 wells. The company also offers midstream energy services, including gathering, transmission, processing, fractionation, and marketing to producers of natural gas, NGLs, crude oil, and condensate through its natural gas pipelines, plants, and treatment facilities. Devon Energy Corporation was founded in 1971 and is headquartered in Oklahoma City, Oklahoma.


Previous ArticleNext Article

Leave a Reply

Your email address will not be published. Required fields are marked *